Dr. Reddy's Laboratories has launched Obeda, a generic semaglutide injection for Type 2 diabetes, becoming the first Indian company to receive DCGI approval for this GLP-1 receptor agonist. Available ...

Novartis, an innovative medicines company based in Basel, Switzerland, will continue to boost its multidimensional investment strategy in China, by expanding innovation, building manufacturing ...

New disclosures show how pharma groups reduced federal levies last year by assigning profits to low-tax jurisdictions ...

Robbins LLP reminds stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities ...

Ultragenyx Pharmaceutical (RARE) has drawn investor attention after recent share price swings, including a roughly 39% decline over the past 3 months. This has prompted closer scrutiny of its rare ...

Ramky Infrastructure Limited (RIL) today announced the execution of a Concession Agreement between the Maharashtra Industrial Development Corporation (MIDC) and Maha Integrated Life Sciences City ...

AAA Biotech’s Validated Antibodies, Recombinant Proteins, and ELISA Kits Power Breakthrough Research Across Drug ...

We will know even more about the company's prospects in a year as it releases clinical data for various pipeline candidates.

Milestone Pharmaceuticals Inc. (MIST) on Friday reported a loss of $17.4 million in its fourth quarter. On a per-share basis, the Montreal-based company said it had ...

Researchers use a novel process involving engineered Escherichia coli to turn plastic waste into levodopa, a frontline ...

US drugmaker Collegium Pharmaceutical has agreed to buy Corium Therapeutics' attention deficit hyperactivity disorder (ADHD) drug Azstarys (serdexmethylphenidate and dexmethylphenidate) for $650 ...